Scale up: meeting targets in global tuberculosis control (Q34305217)

1 August 2017

Scale up: meeting targets in global tuberculosis control (English)

1 reference

1 August 2017

1 reference

Dermot Maher

3

0 references

Mario Raviglione

object named as

Mario C Raviglione

series ordinal

2

0 references

Gijs Elzinga

series ordinal

1

object named as

Gijs Elzinga

1 reference

PubMed ID

15016493

1 August 2017

language of work or name

English

0 references

publication date

1 March 2004

1 reference

1 August 2017

1 reference

1 August 2017

363

1 reference

1 August 2017

9411

1 reference

1 August 2017

814-819

1 reference

Criteria for the control of drug-resistant tuberculosis

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915698-5

7 January 2021

The dynamics of tuberculosis in response to 10 years of intensive control effort in Peru

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915698-5

7 January 2021

Assessment of worldwide tuberculosis control

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915698-5

7 January 2021

The growing burden of tuberculosis: global trends and interactions with the HIV epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915698-5

7 January 2021

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915698-5

7 January 2021

Resources required for global tuberculosis control

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915698-5

7 January 2021

Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Directly observed short-course therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915698-5

7 January 2021

What is the limit to case detection under the DOTS strategy for tuberculosis control?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915698-5

7 January 2021

Private practitioners and public health: weak links in tuberculosis control

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915698-5

7 January 2021

Tuberculosis in prisons in countries with high prevalence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915698-5

7 January 2021

Evolution of WHO policies for tuberculosis control, 1948-2001.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915698-5

7 January 2021

European framework for tuberculosis control and elimination in countries with a low incidence. Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculo

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915698-5

7 January 2021

A global health fund: a leap of faith?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915698-5

7 January 2021

Preventing antiretroviral anarchy in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915698-5

7 January 2021

10.1016/S0140-6736(04)15698-5

Identifiers

DOI

1 reference

release_p2ftdshbznhtpbbkwlqs4onxxa

1 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/p2ftdshbznhtpbbkwlqs4onxxa

24 November 2022

mapped directly with Wikidata item

PubMed ID

15016493

1 reference

PubMed ID

15016493